Production (Stage)
Senti Biosciences, Inc.
SNTI
$3.21
-$0.10-3.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 19.42% | -10.20% | |||
| Gross Profit | -19.42% | 10.20% | |||
| SG&A Expenses | -18.76% | 44.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.58% | 8.89% | |||
| Operating Income | -0.58% | -8.89% | |||
| Income Before Tax | -2,213.44% | 97.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,213.44% | 97.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,213.44% | 97.89% | |||
| EBIT | -0.58% | -8.89% | |||
| EBITDA | -0.70% | -9.65% | |||
| EPS Basic | -4.91% | 78.70% | |||
| Normalized Basic EPS | -421.55% | 88.87% | |||
| EPS Diluted | -4.91% | 78.70% | |||
| Normalized Diluted EPS | -421.55% | 88.87% | |||
| Average Basic Shares Outstanding | 114.82% | 1.84% | |||
| Average Diluted Shares Outstanding | 114.82% | 1.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||